Nitrogen → Cyclopentyl(S)-2-{4-[6-Amino-5-(4-fluorobenzoyl)-2-oxo-2H-pyridin-1-yl]cyclohexyl amino}-3-phenylpropionate

HRID 1667374ノート

反応式

HRID 1667374 の反応式
[NH2:1][C:2]1[N:7]([CH:8]2[CH2:13][CH2:12][C:11](=O)[CH2:10][CH2:9]2)[C:6](=[O:15])[CH:5]=[CH:4][C:3]=1[C:16](=[O:24])[C:17]1[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=1.[CH:25]1([O:30][C:31](=[O:41])[C@H:32]([CH2:34][C:35]2[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=2)[NH2:33])[CH2:29][CH2:28][CH2:27][CH2:26]1.N#N.[BH3-]C#N.[Na+]>CO.CC(O)=O>[NH2:1][C:2]1[N:7]([CH:8]2[CH2:13][CH2:12][CH:11]([NH:33][C@@H:32]([CH2:34][C:35]3[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=3)[C:31]([O:30][CH:25]3[CH2:26][CH2:27][CH2:28][CH2:29]3)=[O:41])[CH2:10][CH2:9]2)[C:6](=[O:15])[CH:5]=[CH:4][C:3]=1[C:16](=[O:24])[C:17]1[CH:18]=[CH:19][C:20]([F:23])=[CH:21][CH:22]=1

参加物

7

反応物 4

HCID 947NitrogenHCID 5003444Sodium cyanoborohydrideHCID 53840847Cyclopentyl (2S)-2-amino-3-phenylpropanoateHCID 576584256-Amino-5-(4-fluorobenzoyl)-1-(4-oxo-cyclohexyl)-1H-pyridin-2-one

生成物 1

HCID 57658387Cyclopentyl(S)-2-{4-[6-Amino-5-(4-fluorobenzoyl)-2-oxo-2H-pyridin-1-yl]cyclohexyl amino}-3-phenylpropionate

試薬・触媒・溶媒 2

HCID 176Acetic Acid溶媒HCID 887Methanol溶媒

実験手順

Intermediate 6 (50 mg, 0.15 mmol) was added to a colourless solution of L-phenylalanine cyclopentyl ester (89 mg, 0.38 mmol) in MeOH (10 ml) at RT/N2 and stirred at RT for 1 h. AcOH glacial was added dropwise to adjust the pH to 6 followed by the NaCNBH3 (38 mg, 0.61 mmol). The resultant colourless solution was stirred at RT overnight and then carefully quenched with sat. NaHCO3 (20 ml) and extracted into CH2Cl2 (3×15 ml). The combined organic phases were washed with 2M HCl (2×20 ml), brine (20 ml), dried (Na2SO4), filtered and concentrated in vacuo giving a cream coloured solid. Purification by flash column chromatography (silica, gradient elution 40-100% EtOAc/heptane) gave the desired material, separable as two isomers, isomer 1 (Example 34) as a white solid (Yield=39 mg, 47%) LCMS purity 100%, m/z 546 [M+H]+, 1H NMR (400 MHz, CD3OD), δ: 1.40-2.05 (16H, m), 2.85-3.10 (3H, m), 3.60-3.70 (1H, m), 4.55-4.65 (1H, m), 5.10-5.20 (1H, m), 5.70 (1H, d), 7.15-7.40 (7H, m), 7.45-7.50 (1H, m), 7.50-7.60 (2H, m) and isomer 2 (Example 35) LCMS purity 97%, m/z 546 [M+H]+, 1H NMR (400 MHz, CD3OD), δ: 1.25-1.85 (12H, m), 1.95-2.20 (2H, m), 2.45-2.95 (4H, m), 3.00-3.10 (1H, m), 3.65-3.75 (1H, m), 4.55-4.65 (1H, m), 5.05-5.15 (1H, m), 5.65 (1H, d), 7.20-7.35 (7H, m), 7.40-7.50 (1H, m), 7.50-7.60 (2H, m) as a colourless film (Yield=15 mg, 18%).

後処理

  1. stirringThe resultant colourless solution was stirred at RT overnight
  2. customcarefully quenched with sat. NaHCO3 (20 ml)
  3. extractionextracted into CH2Cl2 (3×15 ml)
  4. washThe combined organic phases were washed with 2M HCl (2×20 ml), brine (20 ml)
  5. dry with materialdried (Na2SO4)
  6. filtrationfiltered
  7. concentrationconcentrated in vacuo
  8. customgiving a cream
  9. customPurification
  10. washby flash column chromatography (silica, gradient elution 40-100% EtOAc/heptane)

出典と根拠

ORDレコード
ord-8b786c1b1b494c1185d0dc3996cb081e
出典データセット
uspto-grants-2011_10
特許番号
US08044211B2

反応ノート

読み込み中…